X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2276) 2276
Book Chapter (68) 68
Dissertation (8) 8
Newspaper Article (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1863) 1863
life sciences & biomedicine (1760) 1760
humans (1142) 1142
oncology (884) 884
mek (802) 802
animals (728) 728
mek inhibitors (605) 605
melanoma (514) 514
cell biology (480) 480
mutation (465) 465
signal transduction (451) 451
kinases (447) 447
cell line, tumor (436) 436
cancer (416) 416
biochemistry & molecular biology (407) 407
apoptosis (390) 390
mice (379) 379
extracellular signal-regulated kinase (365) 365
phosphorylation (345) 345
female (342) 342
proteins (317) 317
map kinase (314) 314
mek inhibitor (306) 306
tumors (301) 301
protein kinase inhibitors - pharmacology (294) 294
male (281) 281
erk (253) 253
map kinase signaling system - drug effects (241) 241
braf (230) 230
pharmacology & pharmacy (223) 223
metastasis (219) 219
signal transduction - drug effects (219) 219
inhibitors (210) 210
research (207) 207
gene expression (195) 195
melanoma - drug therapy (194) 194
apoptosis - drug effects (192) 192
cell proliferation (190) 190
extracellular signal-regulated map kinases - metabolism (188) 188
mitogen-activated protein kinase kinases - antagonists & inhibitors (184) 184
antineoplastic agents - pharmacology (182) 182
enzyme inhibitors - pharmacology (176) 176
care and treatment (173) 173
analysis (172) 172
mitogen-activated protein kinase kinases - metabolism (172) 172
cell proliferation - drug effects (166) 166
protein kinase inhibitors - therapeutic use (163) 163
proto-oncogene proteins b-raf - genetics (163) 163
rats (160) 160
genetic aspects (158) 158
cancer therapies (156) 156
metastases (156) 156
patients (154) 154
mitogen-activated protein kinases - metabolism (152) 152
antineoplastic agents - therapeutic use (143) 143
immunotherapy (142) 142
research article (142) 142
map kinase signaling system (141) 141
chemotherapy (139) 139
neoplasms (139) 139
cell cycle (136) 136
trametinib (135) 135
middle aged (132) 132
mapk (131) 131
mek/erk (129) 129
health aspects (127) 127
drug resistance (126) 126
melanoma - pathology (125) 125
proto-oncogene proteins b-raf - antagonists & inhibitors (125) 125
cell growth (123) 123
cells, cultured (123) 123
clinical trials (123) 123
inhibition (123) 123
melanoma - genetics (122) 122
targeted therapy (121) 121
aged (120) 120
map kinase kinase kinases - antagonists & inhibitors (120) 120
ras (120) 120
phosphatidylinositol 3-kinases - metabolism (118) 118
xenograft model antitumor assays (118) 118
lung cancer (115) 115
signaling (115) 115
protein kinases (114) 114
blotting, western (112) 112
cell line (111) 111
drug therapy (110) 110
map kinase kinase 1 - antagonists & inhibitors (110) 110
colorectal cancer (109) 109
phosphorylation - drug effects (109) 109
protein kinase (109) 109
pi3k (106) 106
adult (105) 105
raf protein (105) 105
1-phosphatidylinositol 3-kinase (104) 104
medicine, research & experimental (103) 103
research & experimental medicine (103) 103
science & technology - other topics (103) 103
medicine (102) 102
neurosciences & neurology (102) 102
multidisciplinary sciences (101) 101
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2328) 2328
Chinese (20) 20
German (10) 10
Japanese (10) 10
French (3) 3
Korean (2) 2
Norwegian (2) 2
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2012, Volume 367, Issue 2, pp. 107 - 114
Journal Article
Journal Article
Molecular systems biology, ISSN 1744-4292, 01/2017, Volume 13, Issue 1, pp. 905 - n/a
Treatment of BRAF‐mutant melanomas with MAP kinase pathway inhibitors is paradigmatic of the promise of precision cancer therapy but also highlights problems... 
adaptive and reversible drug resistance | RAF and MEK inhibitors | BRAFV600E melanomas | de‐differentiated NGFRHigh state | melanomas | BRAF | de-differentiated NGFR | state | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Cell Survival - drug effects | Humans | Gene Expression Profiling - methods | Sulfonamides - pharmacology | Nerve Tissue Proteins - genetics | Indoles - administration & dosage | Receptors, Nerve Growth Factor - genetics | Xenograft Model Antitumor Assays | Vemurafenib | Animals | MAP Kinase Signaling System - drug effects | Cell Differentiation - drug effects | Melanoma - genetics | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Cell Line, Tumor | Indoles - pharmacology | Cell Proliferation - drug effects | Mice | Gene Expression Regulation, Neoplastic - drug effects | Mutation | Single-Cell Analysis | Sulfonamides - administration & dosage | Drug Resistance, Neoplasm - drug effects | Pharmacology | Microbiology | Kinases | Drug resistance | Cancer therapies | Melanoma | Drugs | Biotechnology | Profiling | Transcription | Xenotransplantation | Raf protein | Drug delivery | Experiments | Cell cycle | Xenografts | Extracellular matrix | Drug dosages | Growth factors | Phenotypes | Statistical analysis | Tumor cells | MEK inhibitors | Cloning | Medical school libraries | MAP kinase | MEK kinase | Gene expression | Neural crest | Variance analysis | Inhibitors | Nerve growth factor receptors | Tumors | Apoptosis | Index Medicus
Journal Article
Oncoimmunology, ISSN 2162-402X, 07/2018, Volume 7, Issue 9, pp. e1468955 - e1468955
.... Targeted therapies based on BRAF and MEK inhibition also seem to have a long-term beneficial effect, which is more evident in patients with favorable baseline characteristics, namely normal levels... 
MEK | immune therapy | BRAF | advanced melanoma | target therapy | mek | braf
Journal Article
PloS one, ISSN 1932-6203, 10/2017, Volume 12, Issue 10, pp. e0185862 - e0185862
Journal Article
9.